Minerva Neurosciences
NERV
72 hedge funds and large institutions have $92.9M invested in Minerva Neurosciences in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 9 closing their positions.
124% more call options, than puts
Call options by funds: $755K | Put options by funds: $337K
33% more capital invested
Capital invested by funds: $70M → $92.9M (+$22.9M)
13% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 23
0.58% more ownership
Funds ownership: 8.61% → 9.19% (+0.58%)
5% less funds holding
Funds holding: 76 → 72 (-4)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$1.55M |
| 2 |
Morgan Stanley
New York
|
+$1.39M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.37M |
| 4 |
AC
Armistice Capital
New York
|
+$1.29M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
+$584K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$772K |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$348K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$195K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$163K |
| 5 |
FM
Frazier Management
Seattle,
Washington
|
-$144K |
NERV Hedge Fund Activity: Q1 2021 in Review
72 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2021, worth a combined $92.9M — up 33% from $70M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of NERV and 5 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 26 added.
The largest buyer was Wells Fargo, adding an estimated $1.55M. The largest seller was Renaissance Technologies, cutting an estimated $772K.
- 72 institutional investors held Minerva Neurosciences (NERV) as of Q1 2021, down from 76 in Q4 2020.
- Funds reported $92.9M of Minerva Neurosciences stock for Q1 2021, up 33% quarter-over-quarter.
- 5 funds opened new Minerva Neurosciences positions in Q1 2021 and 9 closed out, a net change of -4 holders.
- The largest Minerva Neurosciences buyer in Q1 2021 was Wells Fargo, an estimated $1.55M added.
- The largest Minerva Neurosciences seller in Q1 2021 was Renaissance Technologies, an estimated $772K sold.
Based on aggregated 13F filings for Q1 2021.